The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Wolff-Parkinson-White Syndrome

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Wolff-Parkinson-White Syndrome


Psychiatry related information on Wolff-Parkinson-White Syndrome


High impact information on Wolff-Parkinson-White Syndrome


Chemical compound and disease context of Wolff-Parkinson-White Syndrome


Biological context of Wolff-Parkinson-White Syndrome


Anatomical context of Wolff-Parkinson-White Syndrome


Gene context of Wolff-Parkinson-White Syndrome


Analytical, diagnostic and therapeutic context of Wolff-Parkinson-White Syndrome


  1. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. Arad, M., Benson, D.W., Perez-Atayde, A.R., McKenna, W.J., Sparks, E.A., Kanter, R.J., McGarry, K., Seidman, J.G., Seidman, C.E. J. Clin. Invest. (2002) [Pubmed]
  2. Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation. Josephson, M.E., Kastor, J.A., Kitchen, J.G. Ann. Intern. Med. (1976) [Pubmed]
  3. Sotalol in patients with Wolff-Parkinson-White syndrome. Kunze, K.P., Schlüter, M., Kuck, K.H. Circulation (1987) [Pubmed]
  4. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome. Prystowsky, E.N., Klein, G.J., Rinkenberger, R.L., Heger, J.J., Naccarelli, G.V., Zipes, D.P. Circulation (1984) [Pubmed]
  5. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Wellens, H.J., Brugada, P., Abdollah, H., Dassen, W.R. Circulation (1984) [Pubmed]
  6. Possible case of procainamide-induced intrahepatic cholestatic jaundice. Chuang, L.C., Tunier, A.P., Akhtar, N., Levine, S.M. The Annals of pharmacotherapy. (1993) [Pubmed]
  7. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. Gollob, M.H., Green, M.S., Tang, A.S., Gollob, T., Karibe, A., Ali Hassan , A.S., Ahmad, F., Lozado, R., Shah, G., Fananapazir, L., Bachinski, L.L., Roberts, R., Hassan, A.S. N. Engl. J. Med. (2001) [Pubmed]
  8. Pre-excitation syndrome in Leber's hereditary optic neuropathy. Nikoskelainen, E.K., Savontaus, M.L., Huoponen, K., Antila, K., Hartiala, J. Lancet (1994) [Pubmed]
  9. Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine. Exner, D.V., Muzyka, T., Gillis, A.M. Ann. Intern. Med. (1995) [Pubmed]
  10. Procainamide infusion test: inability to identify patients with Wolff-Parkinson-White syndrome who are potentially at risk of sudden death. Fananapazir, L., Packer, D.L., German, L.D., Greer, G.S., Gallagher, J.J., Pressley, J.C., Prystowsky, E.N. Circulation (1988) [Pubmed]
  11. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Gulamhusein, S., Ko, P., Carruthers, S.G., Klein, G.J. Circulation (1982) [Pubmed]
  12. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome. Kerr, C.R., Prystowsky, E.N., Smith, W.M., Cook, L., Gallagher, J.J. Circulation (1982) [Pubmed]
  13. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Sellers, T.D., Campbell, R.W., Bashore, T.M., Gallagher, J.J. Circulation (1977) [Pubmed]
  14. Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility. Sharma, A.D., Klein, G.J., Yee, R. Am. J. Med. (1990) [Pubmed]
  15. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. Vaughan, C.J., Hom, Y., Okin, D.A., McDermott, D.A., Lerman, B.B., Basson, C.T. J. Cardiovasc. Electrophysiol. (2003) [Pubmed]
  16. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia. Sharpe, M.D., Dobkowski, W.B., Murkin, J.M., Klein, G., Yee, R. Anesthesiology (1995) [Pubmed]
  17. Long-term outcome of operative treatment of focal atrial tachycardia. Misaki, T., Watanabe, G., Iwa, T., Ishida, K., Tsubota, M., Matsunaga, Y., Watanabe, Y., Fujiki, A., Inoue, H., Okada, R. J. Am. Coll. Surg. (1995) [Pubmed]
  18. Effects of isoflurane on electrophysiological measurements in children with the Wolff-Parkinson-White syndrome. Chang, R.K., Stevenson, W.G., Wetzel, G.T., Shannon, K., Baum, V.C., Klitzner, T.S. Pacing and clinical electrophysiology : PACE. (1996) [Pubmed]
  19. A surgically treated case of both Wolff-Parkinson-White syndrome and atrial septal defect complicating single coronary artery and partial pericardial defect. Sasaki, Y., Furihata, A., Suyama, K. Japanese heart journal. (1995) [Pubmed]
  20. The effects of atropine on atrio-ventricular conduction in patients with Wolff-Parkinson-White syndrome. Studies with His bundle electrogram. Ito, M. Jpn. Circ. J. (1976) [Pubmed]
  21. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Blair, E., Redwood, C., Ashrafian, H., Oliveira, M., Broxholme, J., Kerr, B., Salmon, A., Ostman-Smith, I., Watkins, H. Hum. Mol. Genet. (2001) [Pubmed]
  22. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Sidhu, J.S., Rajawat, Y.S., Rami, T.G., Gollob, M.H., Wang, Z., Yuan, R., Marian, A.J., DeMayo, F.J., Weilbacher, D., Taffet, G.E., Davies, J.K., Carling, D., Khoury, D.S., Roberts, R. Circulation (2005) [Pubmed]
  23. Corrected transposition with severe intracardiac deformities with Wolff-Parkinson-White syndrome in a child. Electrophysiologic investigation and surgical correction. Benson, D.W., Gallagher, J.J., Oldham, H.N., Sealy, W.C., Sterba, R., Spach, M.S. Circulation (1980) [Pubmed]
  24. Tuberous sclerosis and Wolff-Parkinson-White syndrome. Jayakar, P.B., Stanwick, R.S., Seshia, S.S. J. Pediatr. (1986) [Pubmed]
  25. Proximal trisomy of 1q mosaicism in a girl with hypertrophic cardiomyopathy associated with Wolff-Parkinson-White syndrome and multiple congenital anomalies. Hirshfeld, A.B., Thompson, W.R., Patel, A., Boone, L.B., Murphy, A.M. Am. J. Med. Genet. (2001) [Pubmed]
  26. Wolff-Parkinson-White Syndrome--current views. Chung, E.K. Am. J. Med. (1977) [Pubmed]
  27. Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation. Chimienti, M., Moizi, M., Salerno, J.A., Klersy, C., Guasti, L., Previtali, M., Marangoni, E., Montemartini, C., Bobba, P. Eur. Heart J. (1987) [Pubmed]
  28. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Wellens, H.J., Lie, K.I., Bär, F.W., Wesdorp, J.C., Dohmen, H.J., Düren, D.R., Durrer, D. Am. J. Cardiol. (1976) [Pubmed]
  29. The electrophysiologic effects of intravenous propranolol in the Wolff-Parkinson-White syndrome. Barrett, P.A., Jordan, J.L., Mandel, W.J., Yamaguchi, I., Laks, M.M. Am. Heart J. (1979) [Pubmed]
  30. Effects of intravenous sotalol in patients with atrioventricular accessory pathways. Touboul, P., Atallah, G., Kirkorian, G., Lavaud, P., Mathieu, M.P., Dellinger, A. Am. Heart J. (1987) [Pubmed]
WikiGenes - Universities